http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107349210-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036 |
| filingDate | 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107349210-B |
| titleOfInvention | Compositions having synergistic alpha-amylase inhibitory activity |
| abstract | A composition with synergistic alpha-amylase inhibiting activity comprises triterpenoids and alpha-glucosidase inhibitors. The pharmaceutical composition can more effectively reduce postprandial blood sugar, and uses less alpha-glycosidase inhibitors, thereby improving the drug effect and effectively reducing the toxic and side effects of the alpha-glycosidase inhibitors. |
| priorityDate | 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.